Quick Answer
Autonomix Medical, Inc. reported R&D Expense of $4.72 million for fiscal year 2025.
Autonomix Medical, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $4.72M | +112.4% |
| 2024 | $2.23M | +198.7% |
| 2023 | $745.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $1.72M | +65.1% | -27.2% |
| September 30, 2025 | $2.37M | +101.6% | +48.6% |
| June 30, 2025 | $1.59M | +67.0% | +52.6% |
| December 31, 2024 | $1.04M | +52.0% | -11.1% |
| September 30, 2024 | $1.17M | +149.3% | +23.1% |
| June 30, 2024 | $954.0K | +159.2% | +38.9% |
| December 31, 2023 | $687.0K | +245.2% | +45.9% |
| September 30, 2023 | $471.0K | — | +28.0% |
- Autonomix Medical, Inc. showed an increase of +112.4% in R&D Expense compared to the prior fiscal year.
- Over the 2023–2025 period, Autonomix Medical, Inc.’s r&d expense has grown by 534.2% (from $745.0 thousand to $4.72 million).
- The most recent figure is from Autonomix Medical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: